نتایج جستجو برای: Thrombophilia

تعداد نتایج: 3778  

Background: The role of anticoagulant medications in preventing placental mediated pregnancy complications in patients with and without thrombophilia has not been investigated well. One underlying cause is associated with adverse effects of anticoagulants in pregnancy including teratogenicity, complexities in dosing and management of anticoagulants during pregnancy and labor. We aimed to assess...

Journal: :reports of biochemistry and molecular biology 0
fatemeh keify pardis clinical and genetics laboratory, mashhad, iran. mohsen azimi-nezhad pardis clinical and genetics laboratory, mashhad, iran - department of medical genetics, school of medicine, mashhad university of medical sciences, mashhad, iran - université de lorraine, unité de recherche “interactions gène-environnement en physiopathologie cardio vasculaire” l’umr inserm u 1122, ige-pcv, nancy, france. narges zhiyan-abed pardis clinical and genetics laboratory, mashhad, iran - razavi’s social welfare organization, mashhad, iran. mojila nasseri pardis clinical and genetics laboratory, mashhad, iran. mohammad reza abbaszadegan tel: +98 5117112343; fax: +98 5117112343

background: thrombophilia is a main predisposition to thrombosis due to a procoagulant state. several point mutations play key roles in blood-clotting disorders, which are grouped under the term thrombophilia. these thrombophilic mutations are methylenetetrahydrofolate reductase (mthfr, c677t, and a1298c), factor v leiden (g1691a), prothrombin gene mutation (factor ii, g20210a), and plasminogen...

Fatemeh Keify, Mohammad Reza Abbaszadegan, Mohsen Azimi-Nezhad, Mojila Nasseri, Narges Zhiyan-abed,

Background: Thrombophilia is a main predisposition to thrombosis due to a procoagulant state. Several point mutations play key roles in blood-clotting disorders, which are grouped under the term thrombophilia. These thrombophilic mutations are methylenetetrahydrofolate reductase (MTHFR, C677T, and A1298C), factor V Leiden (G1691A), prothrombin gene mutation (factor II, G20210A), and plasminogen...

Journal: :reports of biochemistry and molecular biology 0
reza ebrahimzadeh-vesal tel: +98 4115541221; fax: +98 4115541221 roza azam department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran arvin ghazarian department of medical genetics, faculty of medicine, tehran university of medical sciences, tehran, iran mogge hajesmaeili department of biology, islamic azad university of parand, tehran, iran. najmeh ranji department of genetics, faculty of sciences, islamic azad university, rasht branch, rasht, iran. mohammad reza ezzati faculty of medicine, tehran university of medical sciences, tehran, iran.

recurrent pregnancy loss is usually defined as the loss of two or more consecutive pregnancies before 20 weeks of gestation, which occurs in approximately 5% of reproductive-aged women. it has been suggested that women with thrombophilia have an increased risk of pregnancy loss and other adverse pregnancy outcomes. thrombophilia is an important predisposition to blood clot formation and is cons...

Arvin Ghazarian, Mehrdad Sadri, Mogge Hajesmaeili, Mohammad Ali Mohammadi, Mohammad Reza Ezzati, Najmeh Ranji, Reza Ebrahimzadeh-Vesal, Roza Azam, Siamak Khavandi,

Recurrent pregnancy loss is usually defined as the loss of two or more consecutive pregnancies before 20 weeks of gestation, which occurs in approximately 5% of reproductive-aged women. It has been suggested that women with thrombophilia have an increased risk of pregnancy loss and other adverse pregnancy outcomes. Thrombophilia is an important predisposition to blood clot formation and is cons...

Journal: :Collegium antropologicum 2013
Josip Juras Marina Ivanisević Slavko Oresković Slobodan Mihaljević Goran Vujić Josip Delmis

A pregnant woman with inherited thrombophilia (factor II mutation--20210A) had two late pregnancy losses. The first pregnancy was not well documented, but the second pregnancy was complicated by fetal thrombophilia and umbilical artery thrombosis, proven after fetal death. During the third pregnancy enoxaparine was introduced in the therapy and early amniocentesis was performed. Fetal thromboph...

Journal: : 2022

Abstract Thrombophilia is a blood coagulation disorder, in which has an increased tendency to clot, with both arterial and venous localization, being responsible for multiple manifestations: secondary hypertension, stroke, acute pancreatitis or intracardiac masses. We are presenting the case of 21-year-old male patient, hypertensive, known thrombophilia, who was sent echocardiographic evaluatio...

A Aaleyasin L Safdarian M Aghahossieni M Rashidi, S Asadollah Z Najmi,

a:4:{s:10:"Background";s:363:"The largest percentage of failed in vitro fertilization (IVF) cycles are due to lack of implantation. As hereditary thrombophilia can cause in placentation failure, it may have a role in recurrent IVF failure. The aim of this case-control study was to determine whether or not hereditary thrombophilia is more prevalent in women with recurrent IVF failures.";s:19:"Ma...

Journal: :Circulation. Cardiovascular genetics 2016
Bakhtawar K Mahmoodi Nic J G M Veeger Saskia Middeldorp Willem M Lijfering Jan-Leendert P Brouwer Jur Ten Berg Karly Hamulyák Karina Meijer

BACKGROUND Hereditary thrombophilia is associated with a slightly increased risk of arterial thromboembolism (ATE). Whether hereditary thrombophilia interacts with traditional cardiovascular risk factors on the risk of ATE has yet to be established. METHODS AND RESULTS A total of 1891 individuals belonging to 4 family cohorts from the Netherlands were included in the analyses. Five hereditary...

Journal: :Practical Neurology 2002

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید